EGFR and non-small cell lung carcinoma: To date, five works have assessed this hypothesis, and demonstrates high median radon concentrations in NSCLC patients harbouring ALK rearrangements, as EGFR or BRAF mutations among others, although with a poor statistical power given the limited study sample sizes.